Pegah Heidarian
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Pegah Heidarian has a total of 23 co-authors. Here are the top co-authors by number of shared publications:
- Masoud Mohammadi
Research Center for Social Determinants of Health Jahrom University of Medical Sciences Jahrom Iran
7 shared publications - Nader Salari
Department of Biostatistics, School of Health, Kermanshah University of Medical Sciences, Kermanshah, Iran
7 shared publications - Fateme Babajani
Department of Clinical Psychology, Faculty of Medicine, Kermanshah University of Medical Sciences, Kermanshah, Iran
3 shared publications - Amin Hosseinian-Far
Department of Business Analytics & Systems, University of Hertfordshire, Hatfield, UK
2 shared publications - Amir Abdolmaleki
Department of Operating Room, Nahavand School of Allied Medical Sciences, Hamadan University of Medical Sciences, Hamadan, Iran
2 shared publications - Amir Jalali
Department of Psychiatric Nursing, School of Nursing and Midwifery, Kermanshah University of Medical Sciences, Kermanshah, Iran
2 shared publications
Latest Publications
- Open Access
- 28 September 2026
- Published by Springer Nature in BMC Psychology
- Vol. 14 (1) , 1400
Response to: Matters Arising from Salari et al. (2025): Why it is (currently) impossible to estimate accurate prevalence rates of the Impostor Phenomenon
- 28 September 2026
- Published by Springer Nature in BMC Psychology
- Vol. 14 (1) , 1400
Open AccessResponse to: Matters Arising from Salari et al. (2025): Why it is (currently) impossible to estimate accurate prevalence rates of the Impostor Phenomenon
- 31 October 2025
- Published by Springer Nature in Sexuality and Disability
- Vol. 43 (4) , 1-13
The Global Prevalence of Sexual Dysfunction in Migraine Patients: A Systematic Review and Meta-Analysis
- 31 October 2025
- Published by Springer Nature in Sexuality and Disability
- Vol. 43 (4) , 1-13
The Global Prevalence of Sexual Dysfunction in Migraine Patients: A Systematic Review and Meta-Analysis
- Open Access
- 18 October 2025
- Published by Springer Nature in Current Addiction Reports
- Vol. 12 (1) , 1
Correction to: Global Prevalence of Sleep Disorders in Patients Undergoing Methadone Treatment: A Systematic Review and Meta-analysis
- 18 October 2025
- Published by Springer Nature in Current Addiction Reports
- Vol. 12 (1) , 1
Open AccessCorrection to: Global Prevalence of Sleep Disorders in Patients Undergoing Methadone Treatment: A Systematic Review and Meta-analysis
- 21 August 2025
- Published by Springer Nature in Current Addiction Reports
- Vol. 12 (1) , 1-13
Global Prevalence of Sleep Disorders in Patients Undergoing Methadone Treatment: A Systematic Review and Meta-analysis
- 21 August 2025
- Published by Springer Nature in Current Addiction Reports
- Vol. 12 (1) , 1-13
Global Prevalence of Sleep Disorders in Patients Undergoing Methadone Treatment: A Systematic Review and Meta-analysis
- 29 October 2024
- Published by Springer Nature in Indian Journal of Otolaryngology and Head & Neck Surgery
- Vol. 77 (1) , 216-223
Global Prevalence of Excessive Daytime Sleepiness in Patients with Obstructive Sleep Apnea: A Systematic Review and Meta-Analysis
The prevalence of obstructive sleep apnea (OSA) has increased worldwide in recent years, becoming a significant public health concern. One of the most important complications experienced by individuals with OSA is excessive daytime sleepiness (EDS). This study aims to investigate the prevalence of EDS in patients with OSA through a systematic review and meta-analysis. Electronic databases including PubMed, Scopus, Web of Science, Embase, ScienceDirect, and the Google Scholar search engine were systematically searched for studies investigating the prevalence of EDS in people with OSA up to December 2023. Data analysis was conducted using Comprehensive Meta-Analysis software (Version 2), employing a random effects model. The heterogeneity of the studies was assessed using the I² index. In review of 15 studies with a combined sample size of 42,924 individuals found that the global prevalence of EDS in patients with OSA was 39.9% (95% CI: 34.4–45.7). The regression results indicated that as the sample size increased, the prevalence of EDS in patients with OSA decreased (p < 0.05). Additionally, an increase in the years of the studies conducted was associated with a decrease in the prevalence of EDS in patients with OSA, although this trend was not statistically significant (p = 0.856). Based on the results of this study, the global prevalence of EDS in patients with OSA is significant. Given the increasing prevalence of OSA, it is crucial for health decisionmakers to recognize the importance of this issue, raise public awareness, and address the dangerous effects of EDS on the population.
- 29 October 2024
- Published by Springer Nature in Indian Journal of Otolaryngology and Head & Neck Surgery
- Vol. 77 (1) , 216-223
Global Prevalence of Excessive Daytime Sleepiness in Patients with Obstructive Sleep Apnea: A Systematic Review and Meta-Analysis
The prevalence of obstructive sleep apnea (OSA) has increased worldwide in recent years, becoming a significant public health concern. One of the most important complications experienced by individuals with OSA is excessive daytime sleepiness (EDS). This study aims to investigate the prevalence of EDS in patients with OSA through a systematic review and meta-analysis. Electronic databases including PubMed, Scopus, Web of Science, Embase, ScienceDirect, and the Google Scholar search engine were systematically searched for studies investigating the prevalence of EDS in people with OSA up to December 2023. Data analysis was conducted using Comprehensive Meta-Analysis software (Version 2), employing a random effects model. The heterogeneity of the studies was assessed using the I² index. In review of 15 studies with a combined sample size of 42,924 individuals found that the global prevalence of EDS in patients with OSA was 39.9% (95% CI: 34.4–45.7). The regression results indicated that as the sample size increased, the prevalence of EDS in patients with OSA decreased (p < 0.05). Additionally, an increase in the years of the studies conducted was associated with a decrease in the prevalence of EDS in patients with OSA, although this trend was not statistically significant (p = 0.856). Based on the results of this study, the global prevalence of EDS in patients with OSA is significant. Given the increasing prevalence of OSA, it is crucial for health decisionmakers to recognize the importance of this issue, raise public awareness, and address the dangerous effects of EDS on the population.
- 3 August 2024
- Published by Springer Nature in Sexuality and Disability
- Vol. 42 (3) , 535-551
The Global Prevalence of Sexual Disorder in Patients with Rheumatoid Arthritis: A Systematic Review and Meta-Analysis
- 3 August 2024
- Published by Springer Nature in Sexuality and Disability
- Vol. 42 (3) , 535-551
The Global Prevalence of Sexual Disorder in Patients with Rheumatoid Arthritis: A Systematic Review and Meta-Analysis
- 3 August 2024
- Published by Springer Nature in Indian Journal of Gynecologic Oncology
- Vol. 22 (3) , 1-10
Investigating the Results of PET/MRI Diagnostic Method in Breast Cancer Diagnosis: A Systematic Review
- 3 August 2024
- Published by Springer Nature in Indian Journal of Gynecologic Oncology
- Vol. 22 (3) , 1-10
Investigating the Results of PET/MRI Diagnostic Method in Breast Cancer Diagnosis: A Systematic Review
- Top Cited Papers
- 9 June 2024
- Published by Springer Nature in Journal of Prevention
- Vol. 45 (5) , 795-813
Global Prevalence of Social Anxiety Disorder in Children, Adolescents and Youth: A Systematic Review and Meta-analysis
Social anxiety disorder is a prevalent mental health condition that significantly impairs social interactions, academic performance, and professional functioning in children, adolescents, and youth. This study aimed to investigate the global prevalence of social anxiety disorder across these developmental stages. Six electronic databases (PubMed, Scopus, Web of Science, Embase, ScienceDirect and Google Scholar) were systematically searched for studies related to the prevalence of social anxiety disorder in children, adolescents and youth. Random-effects models were employed for data analysis and Comprehensive Meta-Analysis Version 2.0. Heterogeneity was assessed using the I2 index. A total of 38 studies were included in the final analysis. The global prevalence of social anxiety disorder was estimated to be 4.7% in children, 8.3% in adolescents, and 17% in youth. These findings suggest a progressive increase in the prevalence of SAD across these developmental stages. Considering the prevalence of social anxiety disorder in this study, policymakers can use the findings of this study to inform and develop effective prevention strategies for individuals and communities most susceptible to this disorder.
- 9 June 2024
- Published by Springer Nature in Journal of Prevention
- Vol. 45 (5) , 795-813
Top Cited PapersGlobal Prevalence of Social Anxiety Disorder in Children, Adolescents and Youth: A Systematic Review and Meta-analysis
Social anxiety disorder is a prevalent mental health condition that significantly impairs social interactions, academic performance, and professional functioning in children, adolescents, and youth. This study aimed to investigate the global prevalence of social anxiety disorder across these developmental stages. Six electronic databases (PubMed, Scopus, Web of Science, Embase, ScienceDirect and Google Scholar) were systematically searched for studies related to the prevalence of social anxiety disorder in children, adolescents and youth. Random-effects models were employed for data analysis and Comprehensive Meta-Analysis Version 2.0. Heterogeneity was assessed using the I2 index. A total of 38 studies were included in the final analysis. The global prevalence of social anxiety disorder was estimated to be 4.7% in children, 8.3% in adolescents, and 17% in youth. These findings suggest a progressive increase in the prevalence of SAD across these developmental stages. Considering the prevalence of social anxiety disorder in this study, policymakers can use the findings of this study to inform and develop effective prevention strategies for individuals and communities most susceptible to this disorder.
- Top Cited Papers
- 1 June 2024
- Published by Springer Nature in Journal of Prevention
- Vol. 45 (4) , 611-649
Global Prevalence of Anxiety, Depression, and Stress Among Patients with Skin Diseases: A Systematic Review and Meta-analysis
The changes in human lifestyle over the past few decades have impacted the prevalence of skin diseases within different societies. Skin diseases may result in various physical and mental disorders. The most common mental disorders observed among the patients are stress, anxiety, and depression. This study aims to investigate the global prevalence of anxiety, depression, and stress in patients with skin diseases. In this Systematic Review and Meta-Analysis study, the PubMed, Scopus, Science Direct, Embase, Web of science, and Google Scholar repositories were searched without a lower time limit. Heterogeneity among the identified studies was examined using the I2 index, and accordingly random effects model was adopted for analysis. Data analysis was conducted within the Comprehensive Meta-Analysis software (v. 2). In total, 113 studies were included for the final analysis. The overall pooled prevalence of stress, depression, and anxiety in skin disease patients was found to be 39.4%, 27.2% and 28.8%, respectively. Among patients with psoriasis, acne, vitiligo or atopic dermatitis diseases, the highest number of patients suffering from stress was related to patients with acne (75.7%). The highest prevalence of depression, and anxiety was reported in patients with vitiligo (38.3%) and acne (36.5%), respectively. Considering the high prevalence of mental disorders among patients with skin diseases and recognising the impacts of mental health challenges on patients’ well-being, the findings of this study provide valuable insights for identifying specific populations that require targeted interventions for the diagnosis, treatment, and prevention of mental illnesses. Accordingly, healthcare policymakers should incorporate psychological treatment and support measures as integral components of comprehensive care strategies for patients with skin diseases.
- 1 June 2024
- Published by Springer Nature in Journal of Prevention
- Vol. 45 (4) , 611-649
Top Cited PapersGlobal Prevalence of Anxiety, Depression, and Stress Among Patients with Skin Diseases: A Systematic Review and Meta-analysis
The changes in human lifestyle over the past few decades have impacted the prevalence of skin diseases within different societies. Skin diseases may result in various physical and mental disorders. The most common mental disorders observed among the patients are stress, anxiety, and depression. This study aims to investigate the global prevalence of anxiety, depression, and stress in patients with skin diseases. In this Systematic Review and Meta-Analysis study, the PubMed, Scopus, Science Direct, Embase, Web of science, and Google Scholar repositories were searched without a lower time limit. Heterogeneity among the identified studies was examined using the I2 index, and accordingly random effects model was adopted for analysis. Data analysis was conducted within the Comprehensive Meta-Analysis software (v. 2). In total, 113 studies were included for the final analysis. The overall pooled prevalence of stress, depression, and anxiety in skin disease patients was found to be 39.4%, 27.2% and 28.8%, respectively. Among patients with psoriasis, acne, vitiligo or atopic dermatitis diseases, the highest number of patients suffering from stress was related to patients with acne (75.7%). The highest prevalence of depression, and anxiety was reported in patients with vitiligo (38.3%) and acne (36.5%), respectively. Considering the high prevalence of mental disorders among patients with skin diseases and recognising the impacts of mental health challenges on patients’ well-being, the findings of this study provide valuable insights for identifying specific populations that require targeted interventions for the diagnosis, treatment, and prevention of mental illnesses. Accordingly, healthcare policymakers should incorporate psychological treatment and support measures as integral components of comprehensive care strategies for patients with skin diseases.